OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
497259

Soken Chemical & Engineering Co Ltd

Specialty ChemicalsVerified

Soken Chemical & Engineering maintains a strong liquidity position with a current ratio of 2.51 and cash and equivalents of ¥8.41 billion, which supports its operational flexibility. The company's debt-to-equity ratio of 0.11 indicates a conservative capital structure, with long-term debt of ¥4.14 billion compared to total equity of ¥38.00 billion. Free cash flow of ¥4.10 billion and operating cash flow of ¥5.93 billion further reinforce its ability to fund operations and reinvest without external financing. Profitability metrics show a return on equity (ROE) of 11.52% and a return on assets (ROA) of 8.09%, which are strong indicators of efficient capital use and asset management. These figures are in line with the industry's preferred metrics for profitability and returns, suggesting Soken is performing at or above the median for its sector. The company operates in two business divisions: Chemicals and Device System. The Chemicals division focuses on adhesives, fine particles, and special performance materials, while the Device System division handles the sale of devices, engineering services, and maintenance. The financial data does not provide a breakdown of revenue by segment, but the company's operations are primarily concentrated in Japan, with no significant international revenue disclosed. Looking at growth, Soken Chemical & Engineering reported revenue of ¥47.63 billion in the latest period. Analysts had estimated revenue at ¥45.90 billion, indicating the company outperformed expectations. The company's operating income of ¥6.21 billion and net income of ¥4.38 billion suggest a stable and profitable business model. The outlook for the current fiscal year is positive, with analysts forecasting continued performance. Risk factors for Soken Chemical & Engineering are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's conservative capital structure and strong cash reserves reduce the likelihood of near-term financial distress. Additionally, the absence of dilution potential and the low risk of equity issuance in the near term supports a stable shareholder value proposition. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial results were in line with or exceeded analyst expectations, and there are no disclosed regulatory or operational risks that would significantly impact its performance. The company's focus on engineering services and chemical manufacturing remains stable, with no major strategic shifts reported.

30-day price · 4972(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySoken Chemical & Engineering Co Ltd
Ticker4972.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Soken Chemical & Engineering Co., Ltd. is primarily engaged in the manufacture and sale of chemicals, the sale of devices and systems, as well as the provision of engineering services for manufacturing systems.

Classification. Soken Chemical & Engineering is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Soken Chemical & Engineering maintains a strong liquidity position with a current ratio of 2.51 and cash and equivalents of ¥8.41 billion, which supports its operational flexibility. The company's debt-to-equity ratio of 0.11 indicates a conservative capital structure, with long-term debt of ¥4.14 billion compared to total equity of ¥38.00 billion. Free cash flow of ¥4.10 billion and operating cash flow of ¥5.93 billion further reinforce its ability to fund operations and reinvest without external financing. Profitability metrics show a return on equity (ROE) of 11.52% and a return on assets (ROA) of 8.09%, which are strong indicators of efficient capital use and asset management. These figures are in line with the industry's preferred metrics for profitability and returns, suggesting Soken is performing at or above the median for its sector. The company operates in two business divisions: Chemicals and Device System. The Chemicals division focuses on adhesives, fine particles, and special performance materials, while the Device System division handles the sale of devices, engineering services, and maintenance. The financial data does not provide a breakdown of revenue by segment, but the company's operations are primarily concentrated in Japan, with no significant international revenue disclosed. Looking at growth, Soken Chemical & Engineering reported revenue of ¥47.63 billion in the latest period. Analysts had estimated revenue at ¥45.90 billion, indicating the company outperformed expectations. The company's operating income of ¥6.21 billion and net income of ¥4.38 billion suggest a stable and profitable business model. The outlook for the current fiscal year is positive, with analysts forecasting continued performance. Risk factors for Soken Chemical & Engineering are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's conservative capital structure and strong cash reserves reduce the likelihood of near-term financial distress. Additionally, the absence of dilution potential and the low risk of equity issuance in the near term supports a stable shareholder value proposition. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial results were in line with or exceeded analyst expectations, and there are no disclosed regulatory or operational risks that would significantly impact its performance. The company's focus on engineering services and chemical manufacturing remains stable, with no major strategic shifts reported.
Key takeaways
  • Soken Chemical & Engineering maintains a conservative capital structure with a low debt-to-equity ratio of 0.11 and strong liquidity.
  • The company's profitability metrics, including ROE of 11.52% and ROA of 8.09%, are in line with industry standards.
  • Soken outperformed analyst revenue expectations, with actual revenue of ¥47.63 billion compared to an estimated ¥45.90 billion.
  • The company's risk profile is low, with no immediate liquidity or dilution concerns.
  • Soken's operations are primarily concentrated in Japan, with no significant international revenue disclosed.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$47.63B
Gross profit$15.78B
Operating income$6.21B
Net income$4.38B
R&D
SG&A
D&A
SBC
Operating cash flow$5.93B
CapEx-$1.90B
Free cash flow$4.10B
Total assets$54.11B
Total liabilities$16.11B
Total equity$38.00B
Cash & equivalents$8.41B
Long-term debt$4.14B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$38.00B
Net cash$4.28B
Current ratio2.5
Debt/Equity0.1
ROA8.1%
ROE11.5%
Cash conversion1.4%
CapEx/Revenue-4.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4972Activity
Op margin13.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin9.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin33.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity11.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean EPS estimate229.00 JPY
Last actual EPS264.18 JPY
Mean revenue estimate45,900,000,000 JPY
Last actual revenue47,633,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 04:32 UTC#f1d106f6
Market quoteclose JPY 3310.00 · shares 0.02B diluted
no public URL
2026-05-07 04:32 UTC#05558e57
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 12:42 UTCJob: 7d15b7e5